Earli Company Profile: Funding, Investors & Partnerships

Earli

Earli is developing a radically new technique originally from Stanford University. Instead of searching, we force cancer cells to produce synthetic biomarkers that do not belong in the human body, which are then highly detectable and localizable in a PET scanner. We use biology for this, not chemistry, which allows for massive signal amplification. And the same technique also allows us to ultimately destroy the cancer.Earli is developing a radically new technique originally from Stanford University. Instead of search Show More

Alpha Score

57.1

Total Funding$ 59.50 M